145 related articles for article (PubMed ID: 26546433)
1. PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer.
Yi Q; Dong F; Lin L; Liu Q; Chen S; Gao F; He Q
Tumour Biol; 2016 May; 37(5):5805-10. PubMed ID: 26546433
[TBL] [Abstract][Full Text] [Related]
2. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
[TBL] [Abstract][Full Text] [Related]
3. PRSS1 intron mutations in patients with pancreatic cancer and chronic pancreatitis.
Gao F; Liu QC; Zhang S; Zhuang ZH; Lin CZ; Lin XH
Mol Med Rep; 2012 Feb; 5(2):449-51. PubMed ID: 22109105
[TBL] [Abstract][Full Text] [Related]
4. PRSS1_p.Leu81Met mutation results in autoimmune pancreatitis.
Gao F; Li YM; Hong GL; Xu ZF; Liu QC; He QL; Lin LQ; Weng SH
World J Gastroenterol; 2013 Jun; 19(21):3332-8. PubMed ID: 23745036
[TBL] [Abstract][Full Text] [Related]
5. Novel mutations of PRSS1 gene in patients with pancreatic cancer among Han population.
Zeng K; Liu QC; Lin JH; Lin XH; Zhuang ZH; Gao F; Ou QS
Chin Med J (Engl); 2011 Jul; 124(13):2065-7. PubMed ID: 22088471
[TBL] [Abstract][Full Text] [Related]
6. A Thai family with hereditary pancreatitis and increased cancer risk due to a mutation in PRSS1 gene.
Pho-Iam T; Thongnoppakhun W; Yenchitsomanus PT; Limwongse C
World J Gastroenterol; 2005 Mar; 11(11):1634-8. PubMed ID: 15786540
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of protease and anti-protease in serum of patients with pancreatic cancer.
Buamah PK; Skillen AW
Clin Chem; 1985 Jun; 31(6):876-7. PubMed ID: 2581724
[TBL] [Abstract][Full Text] [Related]
9. POLE gene hotspot mutations in advanced pancreatic cancer.
Guenther M; Veninga V; Kumbrink J; Haas M; Westphalen CB; Kruger S; Heinemann V; Kirchner T; Boeck S; Jung A; Ormanns S
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2161-2166. PubMed ID: 30194485
[TBL] [Abstract][Full Text] [Related]
10. Human cationic trypsinogen but not serine peptidase inhibitor, Kazal type 1 variants increase the risk of type 1 autoimmune pancreatitis.
Chang MC; Jan IS; Liang PC; Jeng YM; Yang CY; Tien YW; Wong JM; Chang YT
J Gastroenterol Hepatol; 2014 Dec; 29(12):2038-42. PubMed ID: 24909264
[TBL] [Abstract][Full Text] [Related]
11. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer.
Liu Q; Guo L; Zhang S; Wang J; Lin X; Gao F
Mol Med; 2019 Sep; 25(1):44. PubMed ID: 31521106
[TBL] [Abstract][Full Text] [Related]
12. The -409 C/T genotype of PRSS1 protects against pancreatic cancer in the Han Chinese population.
Liu Q; Lin X; Liu J; Liu A; Gao F
Dig Dis Sci; 2012 Feb; 57(2):573-9. PubMed ID: 21922221
[TBL] [Abstract][Full Text] [Related]
13. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
Grocock CJ; Rebours V; Delhaye MN; Andrén-Sandberg A; Weiss FU; Mountford R; Harcus MJ; Niemczyck E; Vitone LJ; Dodd S; Jørgensen MT; Ammann RW; Schaffalitzky de Muckadell O; Butler JV; Burgess P; Kerr B; Charnley R; Sutton R; Raraty MG; Devière J; Whitcomb DC; Neoptolemos JP; Lévy P; Lerch MM; Greenhalf W;
Gut; 2010 Mar; 59(3):357-63. PubMed ID: 19951905
[TBL] [Abstract][Full Text] [Related]
14. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
[TBL] [Abstract][Full Text] [Related]
15. Multisite mutations of the PRSS1 gene in a Chinese patient with chronic pancreatitis.
Liu QC; Gao F; Cheng ZJ; Ou QS
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):331-2. PubMed ID: 18522894
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the clinical significance of antigenic and functional levels of α1-proteinase inhibitor (α1-Pi) in infiltrating ductal breast carcinomas.
Anes AB; Nasr HB; Hammann P; Kuhn L; Trimeche M; Hamrita B; Bougmiza I; Chaieb A; Khairi H; Chahed K
Clin Biochem; 2012 Nov; 45(16-17):1421-31. PubMed ID: 22841602
[TBL] [Abstract][Full Text] [Related]
17. Three female familial cases of solid pseudopapillary tumors with a protease serine 1 gene mutation.
Gou S; Yu J; Wang C; Liu T; Cui P; Li X
Pancreas; 2013 Jan; 42(1):168-73. PubMed ID: 22722260
[TBL] [Abstract][Full Text] [Related]
18. High serum trypsin levels and the -409 T/T genotype of PRSS1 gene are susceptible to neonatal sepsis.
Chen Q; Xue H; Chen M; Gao F; Xu J; Liu Q; Yang X; Zheng L; Chen H
Inflammation; 2014 Oct; 37(5):1751-6. PubMed ID: 24777884
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of PRSS1, SPINK1 and CFTR gene in patients with alcoholic and idiopathic chronic pancreatitis: A single center study.
Şişman G; Tuğcu M; Ayla K; Sebati Ö; Şentürk H
Turk J Gastroenterol; 2015 Mar; 26(2):176-80. PubMed ID: 25835118
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
